US Stock MarketDetailed Quotes
KALA KALA BIO
- 6.4886
- -0.4214-6.10%
Close Nov 26 16:00 ET
29.91MMarket Cap-556P/E (TTM)
7.0100High6.1500Low72.99KVolume7.0100Open6.9100Pre Close478.09KTurnover2.62%Turnover RatioLossP/E (Static)4.61MShares10.970052wk High4.36P/B18.10MFloat Cap4.210052wk Low--Dividend TTM2.79MShs Float1337.5000Historical High--Div YieldTTM12.45%Amplitude3.5440Historical Low6.5490Avg Price1Lot Size
KALA BIO Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -60.06%-4.73M | -21.33%-9.22M | -11.98%-10.84M | 64.61%-27.93M | 43.97%-7.7M | 81.16%-2.95M | 70.12%-7.6M | 59.80%-9.68M | 27.10%-78.91M | 50.78%-13.74M |
| Net income from continuing operations | -2.83%-8.95M | 8.01%-9.58M | 18.32%-11.81M | 5.85%-42.2M | 32.83%-8.63M | -129.94%-8.7M | 62.96%-10.41M | 56.12%-14.46M | 68.57%-44.82M | 73.00%-12.84M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -923.21%-44.41M | --0 |
| Depreciation and amortization | -20.25%63K | -20.78%61K | -14.29%66K | -43.58%303K | -12.50%70K | -47.68%79K | -48.32%77K | -50.96%77K | -44.92%537K | -62.26%80K |
| Other non cash items | 114.90%839K | -24.64%468K | -71.01%567K | -204.32%-2.39M | -52.77%666K | -1,447.37%-5.63M | 392.92%621K | 190.21%1.96M | -89.83%2.29M | -92.85%1.41M |
| Change In working capital | -85.54%1.29M | -370.18%-2.05M | -244.70%-2.05M | 1,711.61%8.9M | 34.80%-2.18M | 500.63%8.9M | -9.65%758K | -72.89%1.41M | 104.63%491K | -10.48%-3.34M |
| -Change in receivables | ---- | ---- | --0 | -99.48%78K | ---- | ---- | ---- | -96.56%80K | 363.00%15.14M | 99.82%-5K |
| -Change in inventory | --0 | --0 | --0 | 341.69%7.54M | --0 | 815.18%5.24M | 107.82%111K | 1,434.76%2.19M | 127.30%1.71M | 427.96%2.72M |
| -Change in prepaid assets | 432.08%2.57M | -339.36%-3.05M | -93.09%378K | 386.51%5.76M | -101.43%-214K | 96.21%-773K | -29.47%1.27M | 229.12%5.47M | 29.73%-2.01M | 1,020.93%14.92M |
| -Change in payables and accrued expense | -127.44%-1.2M | 369.42%1.08M | 62.77%-2.35M | 69.10%-4.33M | 90.60%-1.97M | 9.22%4.36M | -128.00%-399K | -507.95%-6.32M | -383.15%-14M | -10,635.68%-20.97M |
| -Change in other current assets | --0 | ---- | ---- | ---144K | ---1K | --1K | ---- | ---- | --0 | --0 |
| -Change in other current liabilities | -218.31%-84K | -2,433.33%-76K | -630.00%-73K | 96.22%-13K | -688.89%-71K | 745.45%71K | 98.22%-3K | 93.55%-10K | 50.07%-344K | -101.47%-9K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -60.06%-4.73M | -21.33%-9.22M | -11.98%-10.84M | 64.61%-27.93M | 43.97%-7.7M | 81.16%-2.95M | 70.12%-7.6M | 59.80%-9.68M | 27.10%-78.91M | 50.78%-13.74M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -100.93%-90K | 99.64%-36K | 87.96%-13K | -100.68%-429K | -113.73%-7K | -85.03%9.72M | -454.77%-10.03M | 97.87%-108K | -11.42%62.72M | 101.10%51K |
| Net PPE purchase and sale | 67.97%-90K | 78.44%-36K | 87.96%-13K | -182.91%-563K | -113.73%-7K | -9,466.67%-281K | 2.91%-167K | -33.33%-108K | 74.94%-199K | 70.00%51K |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --62.91M | --0 |
| Net investment purchase and sale | --0 | ---- | ---- | 1,575.00%134K | --0 | 400.00%10M | ---- | ---- | -99.99%8K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -100.93%-90K | 99.64%-36K | 87.96%-13K | -100.68%-429K | -113.73%-7K | -85.03%9.72M | -454.77%-10.03M | 97.87%-108K | -11.42%62.72M | 101.10%51K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -550.00%-180K | 387.15%14.97M | 195.31%8.44M | 207.10%8.51M | -92.02%2.54M | 100.10%40K | 30,830.00%3.07M | 1,755.84%2.86M | -118.66%-7.94M | 19,766.25%31.79M |
| Net issuance payments of debt | ---18K | --0 | --0 | 75.02%-10M | --0 | --0 | --0 | -111,011.11%-10M | -15,123.95%-40.04M | -11.11%-10K |
| Net common stock issuance | ---218K | 387.15%14.97M | --0 | -41.70%18.54M | -98.21%570K | --0 | --3.07M | --14.89M | -22.89%31.8M | 18,714.20%31.8M |
| Net preferred stock issuance | --0 | --0 | --8.54M | --1.97M | --1.97M | --0 | --0 | --0 | --0 | ---- |
| Proceeds from stock option exercised by employees | 40.00%56K | --0 | 250.00%21K | -84.72%46K | --0 | -71.01%40K | --0 | -96.32%6K | -81.01%301K | --0 |
| Net other financing activities | --0 | --0 | 94.17%-119K | ---2.04M | --0 | --0 | --0 | ---2.04M | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -550.00%-180K | 387.15%14.97M | 195.31%8.44M | 207.10%8.51M | -92.02%2.54M | 100.10%40K | 30,830.00%3.07M | 1,755.84%2.86M | -118.66%-7.94M | 19,766.25%31.79M |
| Net cash flow | ||||||||||
| Beginning cash position | 10.03%54.2M | -24.03%48.48M | -28.06%50.9M | -25.44%70.75M | 6.50%56.06M | 13.84%49.26M | -3.13%63.81M | -25.44%70.75M | 5.71%94.88M | -58.63%52.64M |
| Current changes in cash | -173.38%-5M | 139.29%5.72M | 65.14%-2.42M | 17.75%-19.85M | -128.55%-5.17M | -27.38%6.81M | 35.60%-14.56M | 76.10%-6.93M | -571.16%-24.13M | 155.93%18.1M |
| End cash Position | -12.24%49.2M | 10.03%54.2M | -24.03%48.48M | -28.06%50.9M | -28.06%50.9M | 6.50%56.06M | 13.84%49.26M | -3.13%63.81M | -25.44%70.75M | -25.44%70.75M |
| Free cash flow | -48.93%-4.82M | -18.47%-9.25M | -10.88%-10.86M | 63.98%-28.54M | 44.01%-7.7M | 79.41%-3.23M | 69.49%-7.81M | 59.49%-9.79M | 30.37%-79.22M | 57.76%-13.76M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data